Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Ranga Krishnan, MB, ChB: Evidence-Based Decision-Making in Psychopharmacology
1
x
$
30.00
Antipsychotic Induced Symptomatic Hyperprolactinemia
1
x
$
30.00
K. Ranga R. Krishnan, MD: Informant-Rated Cognitive Symptoms in Normal Aging, Mild Cognitive Impairment, and Dementia
1
x
$
30.00
Antipsychotics Case Study by Yuan-Hwa Chou
1
x
$
30.00
Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine
1
x
$
30.00
Boadie W. Dunlop, MD: Disturbed Glucose Metabolism Among Patients Taking Olanzapine and Typical Antipsychotics
1
x
$
30.00
Philip T. Ninan, MD: Generalized Anxiety Disorder: Diagnosis, Neurobiology, and Treatment
1
x
$
30.00
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
1
x
$
0.00
Generalized Anxiety Disorder: Diagnosis, Neurobiology, and Treatment
1
x
$
30.00
Treatment with Olanzapine: Early Predictors of Weight Gain Risk
1
x
$
30.00
Tyler M. McLeod, BS: Nitric Oxide, Stress, and Depression
1
x
$
30.00
Sanjay J. Mathew, MD: Management of Treatment-Refractory Panic Disorder
1
x
$
30.00
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
1
x
$
30.00
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
1
x
$
30.00
Husseini K. Manji, MD, FRCPC: Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics
1
x
$
30.00
Case Report: A Case of Intellectual Disability with Inappropriate and Challenging Sexual Behavior that was Treated with GNRH Analogues (OPEN ACCESS)
1
x
$
0.00
Efficacy and Tolerability of Two Different Kinds of Titration of Paroxetine Hydrocloride Solution: an Observational Study
1
x
$
30.00
Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine
1
x
$
30.00
Macrophage Migration Inhibitory Factor and Interleukin 1-β mRNA Levels as Predictors of Antidepressant Treatment Response in Major Depression
1
x
$
30.00
Revisiting Lithium: Utility for Behavioral Stabilization in Adolescents and Adults with Autism Spectrum Disorder
1
x
$
30.00
Sublingual Atropine Administration for Clozapine-Induced Sialorrhea in Bipolar Disorder: A Case Report Highlighting its Efficacy, Safety Concerns and Challenges
1
x
$
30.00
View Cart
Checkout
Home
Preethy Kathiresan
“Sublingual Atropine Administration for Clozapine-Induced Sialorrhea in Bipolar Disorder: A Case Report Highlighting its Efficacy, Safety Concerns and Challenges” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Sublingual Atropine Administration for Clozapine-Induced Sialorrhea in Bipolar Disorder: A Case Report Highlighting its Efficacy, Safety Concerns and Challenges
$
30.00
Add to cart
Details
Page load link
Go to Top
